AUG 17, 2026 · JOURNAL ARTICLE
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3
Journal of Clinical Oncology
This is an ASCO clinical practice guideline for stage IV NSCLC with driver alterations, systematically reviewed on an eight-week cycle by expert panel; it provides recommendations for clinical practice rather than reporting original research evidence.